A systematic review of genetic polymorphisms associated with binge eating disorder
The clean label movement, already strong among mainstream consumers, becomes non-negotiable for GLP-1 users
The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health
Dialysis or kidney transplant may be needed. According to a 2022 study published in Frontiers in Endocrinology, the risk of acute kidney injury is higher in patients taking liraglutide compared to exenatide, the active ingredient in Byetta
For patients currently using Wegovy or considering it as a treatment option, this development raises important questions about who might benefit
Each plan is custom-tailored to your body, condition, and goalsbecause true healing requires personalization